A number of other research analysts have also recently commented on UDG. Stifel Nicolaus reaffirmed a hold rating and set a GBX 775 ($10.06) target price on shares of Udg Healthcare PLC in a research note on Thursday, August 3rd. Jefferies Group LLC reaffirmed a hold rating and set a GBX 785 ($10.19) target price on shares of Udg Healthcare PLC in a research note on Thursday, August 3rd. Peel Hunt reaffirmed an add rating and set a GBX 840 ($10.90) target price on shares of Udg Healthcare PLC in a research note on Thursday, August 10th. Numis Securities Ltd reaffirmed a hold rating and set a GBX 765 ($9.93) target price on shares of Udg Healthcare PLC in a research note on Monday, August 14th. Finally, Liberum Capital reaffirmed a buy rating and set a GBX 930 ($12.07) target price on shares of Udg Healthcare PLC in a research note on Thursday, August 3rd. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus price target of GBX 809.14 ($10.50).
Udg Healthcare PLC (LON UDG) opened at 803.50 on Tuesday. The company’s market capitalization is GBX 1.99 billion. The stock’s 50 day moving average price is GBX 837.16 and its 200 day moving average price is GBX 764.41. Udg Healthcare PLC has a 12 month low of GBX 596.00 and a 12 month high of GBX 886.50.
ILLEGAL ACTIVITY NOTICE: “Udg Healthcare PLC (UDG) Stock Rating Reaffirmed by N+1 Singer” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2017/08/19/udg-healthcare-plc-udg-stock-rating-reaffirmed-by-n1-singer.html.
In other news, insider Jez Moulding acquired 18,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 31st. The shares were bought at an average price of GBX 808 ($10.49) per share, with a total value of £145,440 ($188,809.55). Also, insider Chris Corbin sold 100,000 shares of the stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of GBX 813 ($10.55), for a total value of £813,000 ($1,055,432.95).
Udg Healthcare PLC Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.